<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To study the modulation of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> on post-ischemic intestinal and cerebral <z:mp ids='MP_0001845'>inflammatory responses</z:mp> in a ischemic and excitotoxic rat model </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Adult male rats were subjected to bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 15 min and injection of monosodium <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> intraperitoneally, to decapitate them at selected time points </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNF-alpha) level and nuclear factor kappa B (NF-kappaB) activity were determined by enzyme-linked immunosorbant assay (ELISA) and electrophoretic mobility shift assay (EMSA), respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Hemodynamic parameters were monitored continuously during the whole process of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Monosodium <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> (MSG) treated rats displayed statistically significant high levels of TNF-alpha in cerebral and intestinal tissues within the first 6 h of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The rats with <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> showed a minor decrease of TNF-alpha production in cerebral and intestinal tissues </plain></SENT>
<SENT sid="6" pm="."><plain>The rats with <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and treated with MSG displayed statistically significant low levels of TNF-alpha in cerebral and intestinal tissues </plain></SENT>
<SENT sid="7" pm="."><plain>These results correlated significantly with NF-kappaB production calculated at the same intervals </plain></SENT>
<SENT sid="8" pm="."><plain>During experiment, the mean blood pressure and heart rates in <z:hpo ids='HP_0000001'>all</z:hpo> groups were stable </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: <z:chebi fb="6" ids="14321,29987">Glutamate</z:chebi> is involved in the mechanism of intestinal and cerebral <z:mp ids='MP_0001845'>inflammation</z:mp> responses </plain></SENT>
<SENT sid="10" pm="."><plain>The effects of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> on cerebral and intestinal <z:mp ids='MP_0001845'>inflammatory responses</z:mp> after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> are up-regulated at the transcriptional level, through the NF-kappaB signal transduction pathway </plain></SENT>
</text></document>